Imaging of amyloid, tau and synaptic dysfunction in the brains of type 2 diabetic rats ‐ a multitracer PET study

Documenti analoghi

• Prediction of longitudinal synaptic loss in Alzheimer's disease using tau PET and plasma biomarkers
  di: Jie Wang, et al.
  Pubblicazione: (2025)
• Associations of hippocampal volumes, brain hypometabolism, and plasma NfL with amyloid, tau, and cognitive decline
  di: Feng‐Feng Pan, et al.
  Pubblicazione: (2025)
• Connectivity to epicenters of tau accumulation contributes to regional synaptic loss in Alzheimer’s disease
  di: Ying Luan, et al.
  Pubblicazione: (2024)
• Apolipoprotein E and ethnicity interaction effects on amyloid‐PET status among East Asian and Not Hispanic and Latino White people
  di: Size Li, et al.
  Pubblicazione: (2025)
• Metabolic glutamate receptor 5 (mGluR5) is associated with tau pathology in mild Alzheimer's disease
  di: Yan Wang, et al.
  Pubblicazione: (2024)